StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note issued to investors on Wednesday. The brokerage issued a hold rating on the software maker’s stock.
Veradigm Stock Up 1.5 %
Shares of MDRX stock opened at $10.55 on Wednesday. Veradigm has a 12-month low of $5.01 and a 12-month high of $11.80. The business’s fifty day simple moving average is $9.93 and its 200-day simple moving average is $9.71.
Institutional Investors Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new position in Veradigm Inc. (NASDAQ:MDRX – Free Report) in the second quarter, according to its most recent filing with the SEC. The firm bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- How to Invest in Biotech Stocks
- AutoZone Stock Stays in the Zone for Buy-and-Hold Investors
- What is the Euro STOXX 50 Index?
- 2 Robotic Surgery Stocks Challenging Intuitive Surgical’s Lead
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- 3 of the Best Thematic ETFs for Investors in 2025
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
